One year in review
One year in review 2016: novelties in the treatment of rheumatoid arthritis
A. Calabrò1, A.L. Caterino2, E. Elefante3, V. Valentini4, A. Vitale5, R. Talarico6, L. Cantarini7, B. Frediani8
- Rheumatology Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Italy.
- Rheumatology Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Department of Rheumatology, University of Perugia, Italy.
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Italy. cantariniluca@hotmail.com
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Italy.
CER9495
2016 Vol.34, N°3
PI 0357, PF 0372
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 27268779 [PubMed]
Received: 11/04/2016
Accepted : 27/04/2016
In Press: 30/05/2016
Published: 30/05/2016
Abstract
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. The present review is aimed at providing a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last year.
